Myeloperoxidases and polycystic ovary syndrome

References

• Eshermann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–1236.
   PubMedGoogle Scholar
• Chen Y, Osika W, Dangardt F, Gan LM, Strandvik B, Friberg P. High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents. Atherosclerosis 2010, Aug; 211(2):638–642.
   PubMed Web of Science ®Google Scholar
• Pandolfi A, Solini A, Pellegrini G, Mincione G, Di Silvestre S, Chiozzi P, Giardinelli A, Di Marcantonio MC, Piccirelli A, Capani F, et al. Selective insulin resistance affecting nitric oxide release but not plasminogen activator inhibitor-1 synthesis in fibroblasts from insulin-resistant individuals. Arterioscler Thromb Vasc Biol 2005;25:2392–2397.
   PubMed Web of Science ®Google Scholar
• Talbott EO, Zborowski JV, Boudreaux MY, Mchugh-Pemu KP, Sutton-Tyrrell K, Guzick DS. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;89:6061–6067.
   Web of Science ®Google Scholar
• Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159–165.
   PubMed Web of Science ®Google Scholar
• Orio F, Palomba S, Colao A. Cardiovascular risk in women with polycystic ovary syndrome. Fertil Steril 2006;86 (Suppl 1):20–21.
   PubMed Web of Science ®Google Scholar
• Macut D, Damjanovic S, Panidis D, Spanos N, Glisic B, Petakov M, Rousso D, Kourtis A, Bjekic J, Milic N. Oxidised low-density lipoprotein concentration – early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 2006;155:131–136.
   PubMed Web of Science ®Google Scholar
• Pereira IRS, Bertolami MC, Arpad Faludi AA, Campos MF, Ferderbar S, Lima ES, Aldrighi JM, Abdalla DS. Lipid peroxidation and nitric oxide inactivation in postmenopausal women. Arq Bras Cardiol 2003;80:415–423.
   Google Scholar
• Yang J, Cheng Y, Ji R, Zhang C. Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia. Am J Physiol Heart Circ Physiol 2006;291:H3087–H3093.
   Web of Science ®Google Scholar
• Klebanoff SJ. A peroxidase-mediated antimicrobial system in leukocytes. J Clin Invest 1967;46:1078–1085.
   Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970;169:1095–1097.
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Tromb Vasc Biol 2005;25:1102–1111.
   PubMed Web of Science ®Google Scholar
• Astern JM, Pendergraft WF, Falk RJ, Jannette JC, Schmaier AH, Mahid F, Preston GA. Myeloperoxidase interacts with endothelial cell surface cytokeratin 1 and modulates bradykinin production by the plasma kallikrein-kinin system. Am J Pathol 2007;171:349–360.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JFJr, Hazen SL. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004;110:1134–1139.
   PubMed Web of Science ®Google Scholar
• Walker AE, Seibert SM, Donato AJ, Pierce GL, Seals DR. Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension 2010;55:363–369.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Reddy A, Tang WH, Wu Y, Brennan DM, Hsu A, Mann SA, Hammer PL, Hazen SL. Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death. Circulation 2010;122:70–79.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehdor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595–1604.
   PubMed Web of Science ®Google Scholar
• Exner M, Minar E, Mlekusch W, Sabeti S, Amighi J, Lalouschek W, Maurer G, Bieglmayer C, Kieweg H, Wagner O, et al. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. J Am Coll Cardiol 2006;47:2212–2218.
   PubMed Web of Science ®Google Scholar
• Stern ES, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005;54:333–339.
   PubMed Web of Science ®Google Scholar
• Lakhani K, Leonard A, Seifalian AM, Hardiman P. Microvascular dysfunction in women with polycystic ovary syndrome. Hum Reprod 2005;20:3219–3224.
   PubMed Web of Science ®Google Scholar
• Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005;20:2409–2413.
   PubMed Web of Science ®Google Scholar
• Nácul AP, Andrade CD, Schwarz P, de Bittencourt PI Jr, Spritzer PM. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol 2007;133:191–196.
   PubMed Web of Science ®Google Scholar